014491771	014491771	CD	B-NP	O
|	|	NN	I-NP	O
NGH	NGH	NN	I-NP	O
|	|	NN	I-NP	O
48970452	48970452	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8987399	8987399	CD	B-NP	O
|	|	CC	I-NP	O
1/3/2005	1/3/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/21/2005	10/21/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/21/2005	9/21/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
VAL	VAL	NNP	B-NP	O
YAFAIE	YAFAIE	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
discharge	discharge	NN	I-NP	O
summary	summary	NN	I-NP	O
covers	cover	VBZ	B-VP	O
admission	admission	NN	B-NP	O
7/30/05	7/30/05	CD	I-NP	O
until	until	IN	B-NP	O
9/26/05	9/26/05	CD	I-NP	O
PRIMARY	PRIMARY	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Familial	Familial	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
36-year-old	36-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
familial	familial	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
last	last	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
well	well	RB	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
service	service	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
multiple	multiple	JJ	B-NP	O
admissions	admission	NNS	I-NP	O
for	for	IN	B-PP	O
decompensated	decompensate	VBN	B-NP	O
CHF	CHF	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
poor	poor	JJ	B-NP	O
medical	medical	JJ	I-NP	O
and	and	CC	I-NP	O
dietary	dietary	JJ	I-NP	O
compliance	compliance	NN	I-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
gradual	gradual	JJ	B-NP	O
fatigue	fatigue	NN	I-NP	O
and	and	CC	O	O
increasing	increase	VBG	B-VP	O
abdominal	abdominal	JJ	B-NP	O
girth	girth	NN	I-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
feeling	feel	VBG	B-VP	O
``	``	``	O	O
fluid	fluid	NN	B-NP	O
overloaded	overload	VBN	B-VP	O
.	.	.	O	O
''	''	''	O	O

He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
other	other	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Familial	Familial	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
AICD	AICD	NN	I-NP	O
placed	place	VBN	B-VP	O
in	in	IN	B-PP	O
2001	2001	CD	B-NP	O
,	,	,	O	O
last	last	JJ	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
biventricular	biventricular	JJ	I-NP	O
pacing	pacing	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
severe	severe	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
and	and	CC	I-NP	O
tricuspid	tricuspid	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

CURRENT	CURRENT	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
30	30	CD	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
spironolactone	spironolactone	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
200	200	CD	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
,	,	,	O	O
K-Dur	K-Dur	NNP	B-NP	O
20	20	CD	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
folate	folate	VB	B-VP	O
5	5	CD	B-NP	O
once	once	IN	B-SBAR	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
ACE	ACE	NN	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
cause	cause	VBP	B-VP	O
a	a	DT	B-NP	O
cough	cough	NN	I-NP	O
and	and	CC	I-NP	O
rash	rash	NN	I-NP	O
and	and	CC	I-NP	O
lisinopril	lisinopril	NN	I-NP	O
causes	cause	VBZ	B-VP	O
cough	cough	NN	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
smoked	smoke	VBD	B-VP	O
2	2	CD	B-NP	O
packs	pack	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
times	time	NNS	I-NP	O
approximately	approximately	RB	B-NP	O
10	10	CD	I-NP	O
years	year	NNS	I-NP	O
and	and	CC	O	O
drinks	drink	VBZ	B-VP	O
occasional	occasional	JJ	B-NP	O
ethanol	ethanol	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
married	married	JJ	B-ADJP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
work	work	VB	I-VP	O
currently	currently	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
brother	brother	NN	I-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
.	.	.	O	O

EXAMINATON	EXAMINATON	NNP	B-NP	O
DATA	DATA	NNP	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
96	96	CD	I-NP	O
,	,	,	O	O
Pulse	Pulse	NN	B-NP	O
97	97	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
90/70	90/70	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
97	97	CD	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Admission	Admission	NN	B-NP	O
weight	weight	NN	I-NP	O
83.8	83.8	CD	B-NP	O
kilograms	kilogram	NNS	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
angle	angle	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
jaw	jaw	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
2/6	2/6	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

Respiratory	Respiratory	JJ	B-NP	O
exam	exam	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
bibasilar	bibasilar	JJ	I-NP	O
rales	rale	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
distended	distend	VBN	I-VP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
shifting	shift	VBG	I-NP	O
dullness	dullness	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
trace	trace	NN	B-NP	O
bilateral	bilateral	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
VALUES	VALUES	NNS	I-NP	O
:	:	:	O	O
Creatinine	Creatinine	NN	B-NP	B-protein
1.5	1.5	CD	I-NP	I-protein
,	,	,	O	O
sodium	sodium	NN	B-NP	O
129	129	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
2.7	2.7	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
2.2	2.2	CD	I-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	B-DNA
32	32	CD	I-NP	I-DNA
,	,	,	O	O
AST	AST	NN	B-NP	O
31	31	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
40.6	40.6	CD	I-NP	I-protein
,	,	,	O	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
7.3	7.3	CD	B-NP	O
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-protein
281	281	CD	B-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.2	1.2	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
35.4	35.4	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
BNP	BNP	NN	B-NP	B-protein
594	594	CD	I-NP	I-protein
.	.	.	O	O

INITIAL	INITIAL	JJ	B-NP	O
ASSESSMENT	ASSESSMENT	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
36-year-old	36-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
familial	familial	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

Problem	Problem	NNP	B-NP	O
#	#	#	B-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
in	in	IN	B-PP	O
decompensated	decompensate	VBN	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
reports	report	VBZ	B-VP	O
compliance	compliance	NN	B-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
likely	likely	RB	B-ADVP	O
some	some	DT	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
decompensation	decompensation	NN	I-NP	O
is	be	VBZ	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
dietary	dietary	JJ	B-NP	O
indiscretion	indiscretion	NN	I-NP	O
with	with	IN	B-PP	O
foods	food	NNS	B-NP	O
and	and	CC	I-NP	O
fluids	fluid	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
initially	initially	RB	B-ADVP	O
with	with	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
torsemide	torsemide	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
unsuccessful	unsuccessful	JJ	B-ADJP	O
and	and	CC	O	O
a	a	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
drip	drip	NN	I-NP	O
with	with	IN	B-PP	O
BNP	BNP	NN	B-NP	B-protein
drip	drip	NN	I-NP	I-protein
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
reached	reach	VBD	B-VP	O
a	a	DT	B-NP	O
total	total	JJ	I-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
2	2	CD	I-NP	O
to	to	TO	I-NP	O
3	3	CD	I-NP	O
kilograms	kilogram	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
converted	convert	VBN	I-VP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
medicines	medicine	NNS	I-NP	O
including	include	VBG	B-PP	O
torsemide	torsemide	NN	B-NP	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
maintain	maintain	VB	I-VP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
weight	weight	NN	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	I-NP	O
ultrafiltration	ultrafiltration	NN	I-NP	O
was	be	VBD	B-VP	O
attempted	attempt	VBN	I-VP	O
.	.	.	O	O

That	That	DT	B-NP	O
removed	remove	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
900	900	CD	I-NP	O
cc	cc	NN	I-NP	O
of	of	IN	B-PP	O
fluids	fluid	NNS	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
failed	fail	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
intravenous	intravenous	JJ	B-NP	O
access	access	NN	I-NP	O
clotting	clotting	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
frustration	frustration	NN	I-NP	O
with	with	IN	B-PP	O
having	have	VBG	B-VP	O
to	to	TO	B-PP	O
lying	lie	VBG	B-VP	O
still	still	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
converted	convert	VBN	I-VP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
torsemide	torsemide	NN	I-NP	O
and	and	CC	I-NP	O
metolazone	metolazone	NN	I-NP	O
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
200	200	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
metolazone	metolazone	NN	B-NP	O
5	5	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
spironolactone	spironolactone	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
as	as	IN	B-PP	O
an	an	DT	B-NP	O
oral	oral	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Per	Per	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
request	request	NN	I-NP	O
and	and	CC	O	O
reaching	reach	VBG	B-VP	O
a	a	DT	B-NP	O
somewhat	somewhat	RB	I-NP	O
adequate	adequate	JJ	I-NP	O
goal	goal	NN	I-NP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
requested	request	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
would	would	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
CHF	CHF	NN	I-NP	O
nursing	nursing	NN	I-NP	O
staff	staff	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Adamski	Adamski	NNP	I-NP	O
and	and	CC	O	O
although	although	IN	B-SBAR	O
we	we	PRP	B-NP	O
repeatedly	repeatedly	RB	B-ADVP	O
stressed	stress	VBD	B-VP	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
free	free	JJ	B-NP	O
water	water	NN	I-NP	O
restriction	restriction	NN	I-NP	O
and	and	CC	I-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
noncompliant	noncompliant	JJ	B-ADJP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
while	while	IN	B-SBAR	O
inhouse	inhouse	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
optimal	optimal	JJ	B-ADJP	O
hemodynamically	hemodynamically	RB	B-ADVP	O
,	,	,	O	O
but	but	CC	O	O
had	have	VBD	B-VP	O
excellent	excellent	JJ	B-NP	O
followup	followup	NN	I-NP	O
plans	plan	NNS	I-NP	O
and	and	CC	O	O
stated	state	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
would	would	MD	B-VP	O
return	return	VB	I-VP	O
if	if	IN	B-SBAR	O
his	his	PRP$	B-NP	O
condition	condition	NN	I-NP	O
worsened	worsen	VBD	B-VP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
10	10	CD	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
metolazone	metolazone	NN	I-NP	O
5	5	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
spironolactone	spironolactone	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
200	200	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
K-Dur	K-Dur	NN	B-NP	O
60	60	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
pending	pende	VBG	I-NP	O
studies	study	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
CHF	CHF	NN	I-NP	O
nurse	nurse	NN	I-NP	O
in	in	IN	B-PP	O
approximately	approximately	RB	B-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
see	see	VB	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Weyhrauch	Weyhrauch	NNP	I-NP	O
in	in	IN	B-PP	O
clinic	clinic	NN	B-NP	O
within	within	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
2-0710356	2-0710356	CD	B-NP	O
ISSten	ISSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
GANTZ	GANTZ	NN	B-NP	B-protein
,	,	,	O	O
LOYD	LOYD	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KLEINPETER	KLEINPETER	NNP	B-NP	O
,	,	,	O	O
PEDRO	PEDRO	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
5718928	5718928	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
11/6/05	11/6/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/20/05	7/20/05	CD	B-NP	O

